Friday, March 25, 2022

Roche, Bristol Myers Squibb to advance personalised digital pathology solutions

 

  • Collaboration builds on commitment to advance personalised healthcare by helping to improve access to new treatment options for patients with solid tumours
  • Advances in computation and artificial intelligence (AI) in digital pathology are showing promise to meet the demand for more accurate and comprehensive assessment of pathology results to enable improved patient outcomes
  • Leverages Roche's Digital Pathology Open Environment and the collaboration with PathAI, bringing innovative technology faster to clinical trial settings and anatomic pathology laboratories

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.